{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/69315-331#drug","name":"GATIFLOXACIN","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"69315-331"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA213542"},{"@type":"PropertyValue","propertyID":"UNII","value":"81485Y3A9A"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"826cf8c4-4be5-4614-bd42-47c1d0c9df58"}],"activeIngredient":"GATIFLOXACIN ANHYDROUS","administrationRoute":["OPHTHALMIC"],"dosageForm":"SOLUTION","manufacturer":{"@type":"Organization","name":"Leading Pharma, LLC"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA213542","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=826cf8c4-4be5-4614-bd42-47c1d0c9df58","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-331"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-30T19:51:13.509Z"}}